Glucosio Con Sodio Cloruro I Bioindustria L.I.M.

Glucosio con Sodio Cloruro I Bioindustria L.I.M. is an injectable solution that combines sodium chloride and glucose monohydrate as its active ingredients. Formulated for intravenous administration, the product delivers electrolytes, carbohydrate energy, and metabolic support in a sterile liquid. It is marketed in the European Union and is available by prescription for use in clinical settings requiring fluid, electrolyte, or glucose support.

Glucosio con Sodio Cloruro I is indicated for several clinical situations where intravenous fluid, electrolyte, or glucose replacement is required.

- Fluid and electrolyte replacement in patients with dehydration, surgery, or burns. - Treatment of hypoglycemia when oral glucose is not feasible. - Support of parenteral nutrition regimens as a source of carbohydrate and sodium chloride. - Maintenance of plasma volume during peri‑operative care. - Dilution and compatibility agent for certain intravenous medications.

Adverse reactions to the intravenous solution are generally infrequent, but they can be categorized by frequency and severity.

Common: - Mild pain or irritation at the injection site. - Transient nausea or vomiting. - Temporary increase in blood glucose levels. - Mild electrolyte imbalance, such as slight hypernatremia.

Serious: - Severe hypernatremia or hyperchloremia. - Allergic reactions such as urticaria, angioedema, or anaphylaxis. - Fluid overload leading to pulmonary edema.

When prescribing or administering Glucosio con Sodio Cloruro I, clinicians should observe several safety considerations.

- Assess baseline electrolyte status and blood glucose before infusion. - Adjust infusion rate in patients with renal or cardiac impairment to avoid fluid overload. - Use caution in neonates, infants, and elderly patients due to altered fluid distribution. - Monitor for signs of hypernatremia, hyperchloremia, or rapid shifts in plasma osmolality. - Avoid concurrent rapid infusion of other high‑sodium solutions without dose recalculation. - Ensure sterility of the IV line to prevent infection.

The solution may interact with other intravenous agents or systemic medications, influencing electrolyte balance or glucose levels.

Avoid: - Co‑administration with other high‑sodium or hypertonic solutions without adjusting total sodium load. - Simultaneous infusion of potassium‑containing preparations that could cause abrupt electrolyte shifts.

Use with caution: - Diabetic medications (e.g., insulin, oral hypoglycemics) because the glucose component may affect glycemic control. - Loop diuretics or thiazides, which alter sodium excretion. - Corticosteroids, which can increase sodium retention. - Blood transfusions, where rapid volume changes may exacerbate fluid balance issues.